Pharma Journalist - Page 759 of 830 -

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO (Sulbactam-Durlobactam)

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist

Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals

Kedrion Biopharma and Kamada Receive FDA Approval of KEDRAB

FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma

Otsuka & Mylan Announce License Agreement to Commercialize Delamanid (Deltyba™)

FDA Grants Priority Review to Genentech’s Emicizumab for Hemophilia A with Inhibitors

ViraCyte Announces Positive Phase 2 Trial Results

Ethris, AstraZeneca & MedImmune to develop mRNA Therapies for Respiratory Diseases

Pfizer Receives U.S. FDA Approval for BESPONSA (inotuzumab ozogamicin)

Champions Oncology to collaborate with ALCMI to develop unique cohort of PDX models

Medivir Licenses Exclusive Rights to MIV-802 for Greater China to Ascletis